For example, while BRCA1-deficient ovarian carcinomas and triple-negative breast carcinomas show a good response to therapy, this appears to be the opposite for BRCA1-deficient non-triple-negative breast carcinomas and lung carcinomas (37). Here, BRCA1 is linked to triple-negative breast carcinoma.